Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Jun;76(6):3006–3009. doi: 10.1073/pnas.76.6.3006

Morphine and endorphins modulate dopamine turnover in rat median eminence.

S N Deyo, R M Swift, R J Miller
PMCID: PMC383740  PMID: 288082

Abstract

The is evidence that some of the actions of both endogenous and exogenous opioids (e.g., stimulation of prolactin release) are mediated by interaction with catecholaminergic systems. Morphine (1.67, 5, and 15 mg/kg of body weight, intraperitoneally) altered dopamine turnover as measured by the alpha-methyl-p-tyrosine method in the median eminence, neostriatum, and frontal cortex of male Sprague-Dawley rats. The turnover rate of dopamine was reduced in the median eminence and frontal cortex but accelerated in the neostriatum. In the frontal cortex all doses were effective in decreasing dopamine turnover; however, in the median eminence the lowest dose of morphine did not significantly alter dopamine turnover. All three doses accelerated dopamine turnover in the neostriatum. Naloxone effectively reversed the effects of morphine at all doses in all brain areas, whereas it had no effect on turnover when given alone. In the median eminence, neostriatum, and frontal cortex, intraventricular injection of [D-Ala2,D-Leu5]-enkephalin (25 micrograms) or beta-endorphin (15 micrograms) produced the same effects on dopamine turnover as morphine. The actions of these peptides were blocked by naloxone. It is hypothesized that opiates and opioid peptides increase prolactin release by reducing the activity of the tuberoinfundibular dopaminergic system.

Full text

PDF
3006

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beddell C. R., Clark R. B., Hardy G. W., Lowe L. A., Ubatuba F. B., Vane J. R., Wilkinson S. Structural requirements for opioid activity of analogues of the enkephalins. Proc R Soc Lond B Biol Sci. 1977 Sep 5;198(1132):249–265. doi: 10.1098/rspb.1977.0096. [DOI] [PubMed] [Google Scholar]
  2. Ben-Jonathan N., Porter J. C. A sensitive radioenzymatic assay for dopamine, norepinephrine, and epinephrine in plasma and tissue. Endocrinology. 1976 Jun;98(6):1497–1507. doi: 10.1210/endo-98-6-1497. [DOI] [PubMed] [Google Scholar]
  3. Cheung C. Y., Weiner R. I. Supersensitivity of anterior pituitary dopamine receptors involved in the inhibition of prolactin secretion following destruction of the medial basal hypothalamus. Endocrinology. 1976 Sep;99(3):914–917. doi: 10.1210/endo-99-3-914. [DOI] [PubMed] [Google Scholar]
  4. Chihara K., Arimura A., Coy D. H., Schally A. V. Studies on the interaction of endorphins, substance P. and endogenous somatostatin in growth hormone and prolactin release in rats. Endocrinology. 1978 Jan;102(1):281–290. doi: 10.1210/endo-102-1-281. [DOI] [PubMed] [Google Scholar]
  5. Coy D. H., Kastin A. J., Schally A. V., Morin O., Caron N. G., Labrie F., Walker J. M., Fertel R., Berntson G. G., Sandman C. A. Synthesis and opioid activities of stereoisomers and other D-amino acid analogs of methionine-enkephalin. Biochem Biophys Res Commun. 1976 Dec 6;73(3):632–638. doi: 10.1016/0006-291x(76)90857-3. [DOI] [PubMed] [Google Scholar]
  6. Frederickson R. C., Burgis V., Edwards J. D. Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science. 1977 Nov 18;198(4318):756–758. doi: 10.1126/science.561998. [DOI] [PubMed] [Google Scholar]
  7. Gautvik K. M., Kriz M. Stimulation of prolactin synthesis and of adenosine 3':5'-cyclic phosphate formation by prostaglandins and thyroliberin in cultured rat pituitary cells. Biochem J. 1976 Apr 15;156(1):111–117. doi: 10.1042/bj1560111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grandison L., Guidotti A. Regulation of prolactin release by endogenous opiates. Nature. 1977 Nov 24;270(5635):357–359. doi: 10.1038/270357a0. [DOI] [PubMed] [Google Scholar]
  9. Hoffmann P. C., Toon R., Kleinman J., Heller A. The association of lesion-induced reductions in brain monoamines with alterations in striatal carbohydrate metabolism. J Neurochem. 1973 Jan;20(1):69–80. doi: 10.1111/j.1471-4159.1973.tb12105.x. [DOI] [PubMed] [Google Scholar]
  10. Hökfelt T., Johansson O., Fuxe K., Elde R., Goldstein M., Park D., Efendic S., Luft R., Fraser H., Jeffcoate S. Hypothalamic dopamine neurons and hypothalamic peptides. Adv Biochem Psychopharmacol. 1977;16:99–108. [PubMed] [Google Scholar]
  11. Jessell T. M., Iversen L. L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature. 1977 Aug 11;268(5620):549–551. doi: 10.1038/268549a0. [DOI] [PubMed] [Google Scholar]
  12. Kokka N., Garcia J. F., George R., Elliot H. W. Growth hormone and ACTH secretion: evidence for an inverse relationship in rats. Endocrinology. 1972 Mar;90(3):735–743. doi: 10.1210/endo-90-3-735. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Langer G., Ferin M., Sachar E. J. Effect of haloperidol and L-dopa on plasma prolactin in stalk-sectioned and intact monkeys. Endocrinology. 1978 Feb;102(2):367–370. doi: 10.1210/endo-102-2-367. [DOI] [PubMed] [Google Scholar]
  15. Lawson D. M., Gala R. R. The influence of adrenergic, dopaminergic, cholinergic and serotoninergic drugs on plasma prolactin levels in ovariectomized, estrogen-treated rats. Endocrinology. 1975 Feb;96(2):313–318. doi: 10.1210/endo-96-2-313. [DOI] [PubMed] [Google Scholar]
  16. Lawson D. M., Gala R. R. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats. Endocrinology. 1978 Mar;102(3):973–981. doi: 10.1210/endo-102-3-973. [DOI] [PubMed] [Google Scholar]
  17. Locatelli V., Cocchi D., Racagni G., Cattabeni F., Maggi A., Krogsgaard-Larsen P., Müller E. E. Prolactin-inhibiting activity of gamma-aminobutyric acid-mimetic drugs in the male rat. Brain Res. 1978 Apr 21;145(1):173–179. doi: 10.1016/0006-8993(78)90807-7. [DOI] [PubMed] [Google Scholar]
  18. Loh H. H., Brase D. A., Sampath-Khanna S., Mar J. B., Way E. L., Li C. H. beta-Endorphin in vitro inhibition of striatal dopamine release. Nature. 1976 Dec 9;264(5586):567–568. doi: 10.1038/264567a0. [DOI] [PubMed] [Google Scholar]
  19. Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 1977 Jun 9;267(5611):495–499. doi: 10.1038/267495a0. [DOI] [PubMed] [Google Scholar]
  20. Meltzer H. Y., Miller R. J., Fessler R. G., Simonovic M., Fang V. S. Effects of enkephalin in analogues on prolactin release in the rat. Life Sci. 1978 Jun 5;22(21):1931–1937. doi: 10.1016/0024-3205(78)90480-0. [DOI] [PubMed] [Google Scholar]
  21. Ojeda S. R., Castro-Vázquez A., Jameson H. E. Prolactin release in response to blockade of dopaminergic receptors and to TRH injection in developing and adult rats: role of estrogen in determining sex differences. Endocrinology. 1977 Feb;100(2):427–439. doi: 10.1210/endo-100-2-427. [DOI] [PubMed] [Google Scholar]
  22. Plotsky P. M., Gibbs D. M., Neill J. D. Liquid chromatographic-electrochemical measurement of dopamine in hypophysial stalk blood of rats. Endocrinology. 1978 Jun;102(6):1887–1894. doi: 10.1210/endo-102-6-1887. [DOI] [PubMed] [Google Scholar]
  23. Rivier C., Vale W., Ling N., Brown M., Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 1977 Jan;100(1):238–241. doi: 10.1210/endo-100-1-238. [DOI] [PubMed] [Google Scholar]
  24. Rossier J., Battenberg E., Pittman Q., Bayon A., Koda L., Miller R., Guillemin R., Bloom F. Hypothalamic enkephalin neurones may regulate the neurohypophysis. Nature. 1979 Feb 22;277(5698):653–655. doi: 10.1038/277653a0. [DOI] [PubMed] [Google Scholar]
  25. Sar M., Stumpf W. E., Miller R. J., Chang K. J., Cuatrecasas P. Immunohistochemical localization of enkephalin in rat brain and spinal cord. J Comp Neurol. 1978 Nov 1;182(1):17–37. doi: 10.1002/cne.901820103. [DOI] [PubMed] [Google Scholar]
  26. Tolis G., Hickey J., Guyda H. Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man. J Clin Endocrinol Metab. 1975 Oct;41(4):797–800. doi: 10.1210/jcem-41-4-797. [DOI] [PubMed] [Google Scholar]
  27. Walker J. M., Berntson G. G., Sandman C. A., Coy D. H., Schally A. V., Kastin A. J. An analog of enkephalin having prolonged opiate-like effects in vivo. Science. 1977 Apr 1;196(4285):85–87. doi: 10.1126/science.190683. [DOI] [PubMed] [Google Scholar]
  28. Weitzman R. E., Fisher D. A., Minick S., Ling N., Guillemin R. beta-Endorphin secretion of arginine vasopressin in vivo. Endocrinology. 1977 Nov;101(5):1643–1646. doi: 10.1210/endo-101-5-1643. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES